Regulation of human dermal papilla cell production of insulin-like growth factor binding protein-3 by retinoic acid, glucocorticoids, and insulin-like growth factor-1

被引:0
|
作者
Hembree, JR
Harmon, CS
Nevins, TD
Eckert, RL
机构
[1] CASE WESTERN RESERVE UNIV, SCH MED, DEPT PHYSIOL & BIOPHYS, CLEVELAND, OH 44106 USA
[2] CASE WESTERN RESERVE UNIV, SCH MED, DEPT DERMATOL, CLEVELAND, OH 44106 USA
[3] CASE WESTERN RESERVE UNIV, SCH MED, DEPT REPROD BIOL, CLEVELAND, OH 44106 USA
[4] CASE WESTERN RESERVE UNIV, SCH MED, DEPT BIOCHEM, CLEVELAND, OH 44106 USA
[5] HOFFMANN LA ROCHE INC, DERMATOL RES, NUTLEY, NJ 07110 USA
关键词
D O I
10.1002/(SICI)1097-4652(199606)167:3<556::AID-JCP19>3.0.CO;2-1
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Insulin-like growth factor-1 (IGF1) has been reported to stimulate hair elongation and to facilitate maintenance of the hair follicle in anagen phase. However, little is known about IGF1 signaling in the hair follicle. In this study we investigate the effects of IGF1, glucocorticoids, and retinoids on dermal papilla (DP) cell production of insulin-like growth factor binding proteins (IGFBPs). IGFBPs comprise a family of IGF binding proteins that are produced and released by most cell types. They bind to IGFs to either enhance or inhibit IGF activity. In the present report we identify IGFBP-3 as being produced and released by cultured human dermal papilla (DP) cells. IGFBP-3 levels are increased fivefold by retinoic acid, eightfold by dexamethasone, and tenfold by IGF1. DP cells are known to produce IGF1, and so the observed stimulation of DP cell IGFBP-3 production by IGF1 is consistent with the idea that DP cells possess the IGF transmembrane receptor kinase and are autoregulated by IGFs. The level of another IGFBP, tentatively identified as IGFBP-2, is, in contrast, not regulated by these agents. IGFBP-3 has been shown to inhibit the activity of IGFs in a variety of systems. Our results are consistent with a model in which retinoids and glucocorticoids inhibit IGF action on DP cells and surrounding matrix cells by stimulating increased DP cell production of IGFBP-3. The IGFBP-3, in turn, forms a complex with free IGF1 to reduce the concentration of IGF1 available to stimulate hair elongation and maintenance of anagen phase. (C) 1996 Wiley-Liss, Inc.
引用
收藏
页码:556 / 561
页数:6
相关论文
共 50 条
  • [31] Insulin-like growth factor-1 and insulin-like growth factor binding protein-3 as early predictors of growth, body composition, and neurodevelopment in preterm infants
    Paulsen, Megan E.
    Marka, Nicholas
    Lunos, Scott
    Nagel, Emily M.
    Gonzalez Villamizar, Juan David
    Nathan, Brandon
    Ramel, Sara
    JOURNAL OF PERINATOLOGY, 2024, 44 (11) : 1617 - 1623
  • [32] Insulin-like growth factor-1 and insulin-like growth factor binding protein 3 and risk of postoperative cognitive dysfunction
    Jiang, Jue
    Chen, Zhifeng
    Liang, Bing
    Yan, Jia
    Zhang, Ying
    Jiang, Hong
    SPRINGERPLUS, 2015, 4 : 1 - 7
  • [33] Serum levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in relapsing and primary progressive multiple sclerosis
    Wilczak, N
    Ramsaransing, GSM
    Mostert, J
    Chesik, D
    De Keyser, J
    MULTIPLE SCLEROSIS JOURNAL, 2005, 11 (01) : 13 - 15
  • [34] Variation in plasma insulin-like growth factor-1 and insulin-like growth factor binding protein-3: Personal and lifestyle factors (United states)
    Morimoto, LM
    Newcomb, PA
    White, E
    Bigler, J
    Potter, JD
    CANCER CAUSES & CONTROL, 2005, 16 (08) : 917 - 927
  • [35] Evaluation of Insulin-like Growth Factor-1 and Insulin-like Growth Factor Binding Protein-3 Expression Levels in Patients with Chronic Lymphocytic Leukemia
    Ayer, Mesut
    Sakin, Abdullah
    Ay, Selim
    Ayer, Aylin
    Sazak, Elif Gokcen
    Aktan, Melih
    TURKISH JOURNAL OF HEMATOLOGY, 2016, 33 (04) : 335 - 338
  • [36] Variation in Plasma Insulin-like Growth Factor-1 and Insulin-like Growth Factor Binding Protein-3: Personal and Lifestyle Factors (United States)
    Libby M. Morimoto
    Polly A. Newcomb
    Emily White
    Jeannette Bigler
    John D Potter
    Cancer Causes & Control, 2005, 16 : 917 - 927
  • [37] Insulin-like growth factor-1 and insulin-like growth factor binding protein-3 for prostate cancer detection in patients undergoing prostate biopsy
    Ismail, H
    Pollak, M
    Behlouli, H
    Tanguay, S
    Bégin, LR
    Aprikian, AG
    JOURNAL OF UROLOGY, 2002, 168 (06): : 2426 - 2430
  • [39] Associations of genetically predicted circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 with bladder cancer risk
    Tsai, Chia-Wen
    Chang, Wen-Shin
    Xu, Yifan
    Huang, Maosheng
    Bau, Da-Tian
    Gu, Jian
    MOLECULAR CARCINOGENESIS, 2021, 60 (11) : 726 - 733
  • [40] Measurement of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 after delayed separation of whole blood samples
    Hartog, Hermien
    van der Graaf, Winette T. A.
    Wesseling, Jelle
    van der Veer, Eveline
    Boezen, H. Marike
    CLINICAL BIOCHEMISTRY, 2008, 41 (7-8) : 636 - 639